Propanc Biopharma, Inc. Common Stock (PPCB) is a publicly traded the market company. As of July 7, 2026, PPCB trades at $1.61 with a market cap of $4.03M and a P/E ratio of 0.00. PPCB moved -10.64% today. Year to date, PPCB is -87.03%; over the trailing twelve months it is -99.06%. Its 52-week range spans $1.30 to $600.00. Rallies surfaces PPCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Propanc Biopharma, Inc. Common Stock (PPCB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PPCB moved -10.64% today.
| Metric | Value |
|---|---|
| Price | $1.61 |
| Market Cap | $4.03M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $600.00 |
| 52-Week Low | $1.30 |
| Volume | 4.07M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PPCB analyst coverage data. Average price target: $0.00.